GlassScriptPhysician profile
Dennis Paul Han
NPI 1184628992
$4,003.64
in general payments reported to CMS, 2019-2025
27 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $269 · 2021: $349 · 2022: $1,163 · 2023: $757 · 2024: $236 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,215.32 | 2019-2025 | |
| Stryker Corporation | $640.44 | 2019-2025 | Xpress Loprofile, Audion Et Dilation System |
| Smith+Nephew, INC. | $406.96 | 2019-2025 | Tula |
| Intersect Ent, INC. | $329.41 | 2019-2021 | |
| Inspire Medical Systems, INC. | $294.08 | 2022 | |
| Acclarent, INC | $232.22 | 2021-2023 | Trudi Nav Cable |
| Optinose US, INC. | $142.50 | 2019-2021 | |
| Glaxosmithkline, LLC. | $107.35 | 2021-2025 | Nucala |
| Medtronic, INC. | $74.16 | 2024 | Propel |
| Merck Sharp & Dohme LLC | $69.07 | 2021-2025 | Keytruda |
| Genzyme Corporation | $63.52 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $62.63 | 2021-2023 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $55.11 | 2025 | Tezspire |
| Alk-Abello, INC | $52.05 | 2019-2020 | |
| Ethicon US, LLC | $42.89 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $31.38 | 2020 | |
| Phadia US INC. | $26.10 | 2022 | |
| Itamar Medical INC | $21.84 | 2023 | Watchpatone |
| Checkpoint Surgical, INC | $19.57 | 2021 | |
| Phathom Pharmaceuticals, INC. | $18.52 | 2025 | Voquezna |
| Livanova USA, INC. | $18.37 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Hikma Pharmaceuticals USA | $16.16 | 2023 | Ryaltris |
| Bolder Surgical, LLC | $13.91 | 2022 | |
| Olympus America INC. | $13.71 | 2019 | |
| Fortovia Therapeutics, INC. | $12.60 | 2020 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.